Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-26
DOI
10.1038/s41467-019-11296-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
- (2019) Carole Henry et al. Cell Host & Microbe
- AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
- (2018) Surender Khurana et al. npj Vaccines
- Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
- (2017) Edward A. Belongia et al. Expert Review of Vaccines
- Differentiation of germinal center B cells into plasma cells is initiated by high-affinity antigen and completed by Tfh cells
- (2017) Nike J. Kräutler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age
- (2017) Lisa M Dunkle et al. JOURNAL OF INFECTIOUS DISEASES
- Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness
- (2017) Joshua G. Petrie et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
- (2017) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
- (2017) Seth J. Zost et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The microanatomic segregation of selection by apoptosis in the germinal center
- (2017) Christian T. Mayer et al. SCIENCE
- Antigenicity of the 2015–2016 seasonal H1N1 human influenza virus HA and NA proteins
- (2017) Amelia M. Clark et al. PLoS One
- Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain
- (2017) Christopher S. Anderson et al. Scientific Reports
- Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
- (2016) Joshua G. Petrie et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study
- (2016) Terry Nolan et al. VACCINE
- Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations
- (2015) Synnøve Eidem et al. VACCINE
- Clonal and cellular dynamics in germinal centers
- (2014) Gabriel D Victora et al. CURRENT OPINION IN IMMUNOLOGY
- Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization
- (2014) Surender Khurana et al. PLoS One
- H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine
- (2014) Surender Khurana et al. VACCINE
- Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates
- (2013) Suzanne E. Ohmit et al. CLINICAL INFECTIOUS DISEASES
- Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine
- (2013) M. Gaglani et al. JOURNAL OF INFECTIOUS DISEASES
- Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms
- (2013) Yanming An et al. JOURNAL OF PROTEOME RESEARCH
- Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®)
- (2013) Christof David Vinnemeier et al. Human Vaccines & Immunotherapeutics
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas
- (2012) G. D. Victora et al. BLOOD
- Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-Type H5N1 Influenza Challenge and Controls Viral Loads Better than Subunit H5N1 Vaccine by Eliciting High-Affinity Antibodies
- (2012) S. Verma et al. JOURNAL OF VIROLOGY
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
- (2012) N. Pica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
- (2012) C. A. Thomson et al. Frontiers in Immunology
- Immune Response Following H1N1pdm09 Vaccination: Differences in Antibody Repertoire and Avidity in Young Adults and Elderly Populations Stratified by Age and Gender
- (2011) Surender Khurana et al. JOURNAL OF INFECTIOUS DISEASES
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines
- (2011) Surender Khurana et al. VACCINE
- Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets
- (2010) S. Khurana et al. JOURNAL OF VIROLOGY
- Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
- (2010) Ana Clara Monsalvo et al. NATURE MEDICINE
- Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus
- (2010) Surender Khurana et al. PLoS One
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
- (2009) Agnieszka Szymczakiewicz‐Multanowska et al. JOURNAL OF INFECTIOUS DISEASES
- Pre‐ and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir
- (2009) Wouter Koudstaal et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
- Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old
- (2009) W.A. Keitel et al. VACCINE
- Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vaccine With Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age
- (2008) T. Nolan et al. PEDIATRICS
- Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
- (2008) Sanae Sasaki et al. PLoS One
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started